SG11202010077TA - Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof - Google Patents

Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Info

Publication number
SG11202010077TA
SG11202010077TA SG11202010077TA SG11202010077TA SG11202010077TA SG 11202010077T A SG11202010077T A SG 11202010077TA SG 11202010077T A SG11202010077T A SG 11202010077TA SG 11202010077T A SG11202010077T A SG 11202010077TA SG 11202010077T A SG11202010077T A SG 11202010077TA
Authority
SG
Singapore
Prior art keywords
compositions containing
derived compounds
chemical analogs
photoprotective compositions
containing malassezia
Prior art date
Application number
SG11202010077TA
Inventor
Michael Einziger
Ann Simpson
Original Assignee
Michael Einziger
Ann Simpson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Einziger, Ann Simpson filed Critical Michael Einziger
Publication of SG11202010077TA publication Critical patent/SG11202010077TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11202010077TA 2018-04-12 2019-04-12 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof SG11202010077TA (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862656769P 2018-04-12 2018-04-12
US201862668007P 2018-05-07 2018-05-07
US201862685800P 2018-06-15 2018-06-15
US201862686912P 2018-06-19 2018-06-19
US201862722412P 2018-08-24 2018-08-24
US201862742657P 2018-10-08 2018-10-08
PCT/US2019/027181 WO2019200232A1 (en) 2018-04-12 2019-04-12 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Publications (1)

Publication Number Publication Date
SG11202010077TA true SG11202010077TA (en) 2020-11-27

Family

ID=66380162

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202010077TA SG11202010077TA (en) 2018-04-12 2019-04-12 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Country Status (14)

Country Link
US (2) US11220491B2 (en)
EP (1) EP3774811A1 (en)
JP (1) JP7454759B2 (en)
KR (1) KR20210075033A (en)
CN (1) CN113015731A (en)
AU (1) AU2019251579A1 (en)
BR (1) BR112020020881A2 (en)
CA (1) CA3096866A1 (en)
IL (1) IL277940A (en)
MX (1) MX2020010800A (en)
PH (1) PH12020551677A1 (en)
SG (1) SG11202010077TA (en)
TW (1) TWI742359B (en)
WO (1) WO2019200232A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019241706A1 (en) * 2018-06-15 2019-12-19 Einziger Michael Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
WO2020041663A1 (en) 2018-08-24 2020-02-27 Einziger Michael Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
EA202092467A1 (en) * 2018-10-08 2021-02-12 Майкл Айнцигер PHOTOPROTECTIVE COMPOSITIONS CONTAINING COMPOUNDS OBTAINED FROM MALASSEZIA AND / OR THEIR CHEMICAL ANALOGUES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317925B1 (en) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti BIS-HETEROCYCLES WITH ANTI-TUMOR AND CHEMOSENSITIZING ACTIVITY.
EP2933935A1 (en) 2014-04-14 2015-10-21 Alcatel Lucent A method of modulating light in a telecommunication network
US9969686B2 (en) * 2014-08-05 2018-05-15 Wisconsin Alumni Research Foundation Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
EA201892030A1 (en) * 2016-03-10 2019-02-28 Майкл Айнцигер MALASSEZIN AND ITS ANALOGUES AS LEANING SKIN AGENTS
CN106916171B (en) 2017-01-11 2019-02-26 华南师范大学 Piezochromic material and its application containing indoles simultaneously [3,2-b] carbazole structure unit
WO2019241706A1 (en) * 2018-06-15 2019-12-19 Einziger Michael Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
WO2020041663A1 (en) * 2018-08-24 2020-02-27 Einziger Michael Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Also Published As

Publication number Publication date
TW201946621A (en) 2019-12-16
JP7454759B2 (en) 2024-03-25
MX2020010800A (en) 2021-01-15
BR112020020881A2 (en) 2021-04-20
KR20210075033A (en) 2021-06-22
CA3096866A1 (en) 2019-10-17
US20190345140A1 (en) 2019-11-14
US11220491B2 (en) 2022-01-11
AU2019251579A1 (en) 2020-11-12
WO2019200232A1 (en) 2019-10-17
IL277940A (en) 2020-11-30
EP3774811A1 (en) 2021-02-17
US20220106297A1 (en) 2022-04-07
PH12020551677A1 (en) 2021-06-28
TW202222307A (en) 2022-06-16
CN113015731A (en) 2021-06-22
TWI742359B (en) 2021-10-11
JP2021521195A (en) 2021-08-26

Similar Documents

Publication Publication Date Title
SG10202111648YA (en) Chemical compounds
IL277940A (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
ZA202007035B (en) Stabilized chemical composition
ZA202000529B (en) Chemical compounds
GB201708203D0 (en) Chemical compounds
IL269204B (en) Chemical compounds
IL281078A (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
IL279454A (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
IL288153A (en) Stabilized formulations containing anti-angptl3 antibodies
IL286024A (en) Stabilized formulations containing anti-il-33 antibodies
EP3398942A4 (en) Substituted oxadiazole chemical compound and composition containing said chemical compound and use thereof
SG11202010991RA (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
GB201704476D0 (en) Chemical compounds
IL282196A (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
IL281125A (en) Sirolimus containing compositions
GB201720989D0 (en) Chemical compounds
GB201706102D0 (en) Chemical compounds
GB201907352D0 (en) Chemical compounds
GB201903745D0 (en) Chemical compounds
GB201818532D0 (en) Chemical compounds
GB201811846D0 (en) Chemical compounds
GB201809423D0 (en) Chemical compounds
GB201807557D0 (en) Chemical compounds
GB201805770D0 (en) Chemical compounds
IL282576B (en) Formulations containing domperidone